Protara Therapeutics, Inc. (TARA): Free Cash Flow
-$56.46M
Year ended 2025-12-31
-$66.49M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$56.46M | n/m | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | -$35.87M | n/m | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | -$37.60M | n/m | 2025-03-05, From 2023-01-01 |
| 2022-12-31 | -$26.58M | n/m | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | -$35.10M | n/m | 2023-03-08, From 2021-01-01 |
| 2020-12-31 | -$24.29M | n/m | 2022-03-09, From 2020-01-01 |
| 2019-12-31 | -$5.49M | n/m | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | -$23.35M | n/m | 2020-03-20, From 2018-01-01 |
| 2017-12-31 | -$22.39M | n/m | 2019-03-13, From 2017-01-01 |
| 2016-12-31 | -$23.96M | n/m | 2019-03-13, From 2016-01-01 |
| 2015-12-31 | -$17.76M | n/m | 2018-03-14, From 2015-01-01 |
| 2014-12-31 | -$10.04M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$6.67M | n/m | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | -$8.30M | n/a | 2015-03-20, From 2012-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | 2025-12-31 | -$56.46M | n/m |
| Instil Bio, Inc. (TIL) | 2024-12-31 | -$55.70M | n/m |
| Compass Therapeutics, Inc. (CMPX) | 2025-12-31 | -$49.17M | n/m |
| Metagenomi Therapeutics, Inc. (MGX) | 2025-12-31 | -$89.47M | n/m |
| enGene Therapeutics Inc. (ENGN) | 2025-10-31 | -$100.72M | n/m |
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | -$104.72M | n/m |
| Agenus Inc (AGEN) | 2025-12-31 | -$77.20M | n/m |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | -$139.73M | n/m |
| Solid Biosciences Inc. (SLDB) | 2025-12-31 | -$157.44M | n/m |
Compare TARA, TIL, CMPX, MGX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗